Street Calls of the Week
SANTA CLARA - Agilent Technologies Inc. (NYSE:A), a $36 billion laboratory technologies company, announced Wednesday it will pay a quarterly dividend of 24.8 cents per share of common stock on October 22, 2025, to shareholders of record as of September 30, 2025. The dividend represents a yield of 0.78%, with the company maintaining consistent dividend payments for 14 consecutive years, according to InvestingPro data.
The laboratory technologies company noted that future dividend timing and amounts remain subject to determination and approval by its board of directors.
Agilent, which provides analytical and clinical laboratory technologies, generated revenue of $6.51 billion in fiscal year 2024 and employs approximately 18,000 people worldwide, according to the press release statement.
The Santa Clara-based company describes itself as a global leader in delivering instruments, software, services, and expertise to laboratory customers.
This dividend announcement represents a regular quarterly payment to Agilent shareholders.
In other recent news, Agilent Technologies reported its third-quarter earnings for 2025, surpassing revenue forecasts with a total of $1.74 billion compared to the anticipated $1.67 billion. The company also met expectations with an earnings per share (EPS) of $1.37. Analyst firm TD Cowen maintained its Buy rating for Agilent, reiterating a price target of $150.00, citing the company’s strong fiscal third-quarter performance and a positive outlook for its pharmaceutical and Chemical & Applied segments. KeyBanc reiterated its Sector Weight rating after Agilent’s earnings beat, highlighting the balanced global performance with significant growth in pharmaceutical and Chemical & Advanced Materials markets.
TD Cowen’s analysis pointed to a notable 6.1% organic growth in the third quarter, which exceeded the consensus expectation of 3.6%. Bernstein SocGen Group maintained a Market Perform rating, with a $125.00 price target, acknowledging Agilent’s fifth consecutive quarter of sequential core revenue acceleration. This consistent growth indicates a continued market recovery for the company. Agilent’s strong performance and positive outlook have been recognized by multiple analyst firms, reflecting confidence in its ongoing business strategy.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.